Sign up to save your podcasts
Or
Share The Biopharma Pod
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Biopharma Pod
The Biopharma Pod episodes
- 3 min
- 2 min
- 3 min
- 2 min
- Happy Holidays 2014 from William Reed Business Media!The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!3 min
- Consolidation prevalent in industry, says third largest CMOAenova says the acquisition of Haupt Pharma and Patheon’s merger with DSM are evidence of consolidation in the CMO industry, as it looks to further increase its global footprint.7 min
- Catalent commits to ADCs by upping its stake in RedwoodCatalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.5 min
- So far, so very good: Pall and ATMI talk integration at interphexWhile there will always be space for stainless steel systems, single-use technology is now mainstream according to Pall and ATMI.5 min
- Patheon and DSM crossover limited, more growth targeted says DPxPatheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.5 min
- To QbD or not to QbD? For biologics it's a must says Cook Pharmica expertThe thorny issue of applying QbD to biopharmaceutical manufacture is a topic of hot debate at Interphex 2014 according to CMO Cook Pharmica.6 min
About The Biopharma Pod
From the publisher's feed
Brought to you by the team behind BioPharma-Reporter.com